Popular
Andrew Wilner, MD, FACP, FAAN
Dejan Jakimovski, MD, PhD
Ashley Baker, MSN, PMHNP
Stanley N. Caroff, MD
Charles Turck, PharmD, BCPS, BCCCP
Jagan Pillai, MD, PhD
Ashley Baker, MSN, PMHNP
Anna Shah, MD
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
Marisa McGinley, DO
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Rhonda Cadena, MD, FNCS, FCCM
W. Brian Gibler, MD, FACEP, FACC, FAHA
Adrian R. Parry-Jones, FRCP, PhD
Stuart Connolly, MD, FRCPC
W. Brian Gibler, MD, FACEP, FACC, FAHA
Greg Albers, MD
Rhonda Cadena, MD, FNCS, FCCM
Stuart Connolly, MD, FRCPC
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
W. Brian Gibler, MD, FACEP, FACC, FAHA
Stuart Connolly, MD, FRCPC
Rhonda Cadena, MD, FNCS, FCCM
Greg Albers, MD
W. Brian Gibler, MD, FACEP, FACC, FAHA
Rhonda Cadena, MD, FNCS, FCCM
Adrian R. Parry-Jones, FRCP, PhD
Stuart Connolly, MD, FRCPC
Andrew Wilner, MD, FACP, FAAN
Marcus E. Peter, PhD
Charles Turck, PharmD, BCPS, BCCCP
Stefano Pluchino, MD, PhD
Andrew Wilner, MD, FACP, FAAN
George Bloom, PhD
- MinuteCE®
What Types of Changes, If Any, Should We Expect with Amyloid-Targeting Therapy?
1.25 program creditsRichard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP